Shaimaa Wahba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shaimaa Wahba has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hasanin
Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt
1 shared publication - Amira Refaie
From the Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt (A.M.H., S.M.A., N.A.A., M.K.E., S.R., T.I.R., M.A., M.E.E., K.A.E., A.R.); and the Department of Anesthesia and Critical Care Medicine, Beni-Suef University, Beni-Suef, Egypt (H.A.H.).
1 shared publication - Ayman Abougabal
Department of Anesthesia, Cairo University, Giza, Egypt
1 shared publication - Bassant Mohamed Abdelhamid
Department of Anaesthesiology, Surgical ICU and Pain Management, Kasr-Alainy Faculty of Medicine, Cairo University, Egypt
1 shared publication - Heba Omar
Anesthesia, Pain Management and Surgical ICU, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publication - Kareem Taha
Department of anesthesia and critical care medicine, Cairo university, 01 elsarayah street, Elmanyal, Cairo, 11559, Egypt
1 shared publication
Latest Publications
- Open Access
- 14 August 2018
- Published by Springer Nature in BMC Anesthesiology
- Vol. 18 (1) , 1-8
Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease
Dexmedetomidine infusion improves oxygenation and lung mechanics in patients with chronic obstructive lung disease; however, its effect in patients with restrictive lung disease has not been thoroughly investigated yet. The aim of this work was to evaluate the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. Forty-two morbidly obese patients scheduled for bariatric surgery were included in the study. Patients were randomized to receive either dexmedetomidine infusion at a bolus dose of 1mcg/Kg followed by infusion at 1 mcg/Kg/hour for 90 min (Dexmedetomidine group), or normal saline infusion (Control group). Both groups were compared with regard to: oxygenation {P/F ratio: PaO2/fraction of inspired oxygen (FiO2)}, lung compliance, dead space, plateau pressure, blood pressure, and heart rate. Dexmedetomidine group showed significant improvement of the PaO2/FiO2 ratio, and higher lung compliance compared to control group by the end of drug infusion. Dexmedetomidine group demonstrated decreased dead space, plateau pressure, blood pressure, and heart rate compared to control group by the end of drug infusion. A 90-min dexmedetomidine infusion resulted in moderate improvement in oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. clinicaltrials.gov : NCT02843698 on 20 July 2016.
- 14 August 2018
- Published by Springer Nature in BMC Anesthesiology
- Vol. 18 (1) , 1-8
Open AccessEvaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease
Dexmedetomidine infusion improves oxygenation and lung mechanics in patients with chronic obstructive lung disease; however, its effect in patients with restrictive lung disease has not been thoroughly investigated yet. The aim of this work was to evaluate the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. Forty-two morbidly obese patients scheduled for bariatric surgery were included in the study. Patients were randomized to receive either dexmedetomidine infusion at a bolus dose of 1mcg/Kg followed by infusion at 1 mcg/Kg/hour for 90 min (Dexmedetomidine group), or normal saline infusion (Control group). Both groups were compared with regard to: oxygenation {P/F ratio: PaO2/fraction of inspired oxygen (FiO2)}, lung compliance, dead space, plateau pressure, blood pressure, and heart rate. Dexmedetomidine group showed significant improvement of the PaO2/FiO2 ratio, and higher lung compliance compared to control group by the end of drug infusion. Dexmedetomidine group demonstrated decreased dead space, plateau pressure, blood pressure, and heart rate compared to control group by the end of drug infusion. A 90-min dexmedetomidine infusion resulted in moderate improvement in oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. clinicaltrials.gov : NCT02843698 on 20 July 2016.